Brief: Pixium Vision Announces Positive Review Of First Results With PRIMA Implant
24/09/2018 17:30
Sept 24 (Reuters) - PIXIUM VISION SA PIX.PA :
* ANNOUNCES POSITIVE REVIEW OF FIRST RESULTS WITH PRIMA, ITS
WIRELESS SUBRETINAL IMPLANT, IN PATIENTS WITH ATROPHIC DRY-AMD
* IN ALL FIVE PATIENTS, IMPLANTS WERE SUCCESSFULLY ACTIVATED
* PRIMA COULD BE SAFELY IMPLANTED
* REHABILITATION AND ASSESSMENT AND FULL SET OF 6-MONTH
INTERIM
RESULTS OF FRENCH FEASIBILITY STUDY EXPECTED TO BE COMPLETED BY
END OF 2018
* THIS WILL ENABLE DESIGN OF PROTOCOL FOR A LARGER
MULTI-CENTRAL
EUROPEAN PIVOTAL STUDY, REQUIRED FOR CE-MARK, TO COMMENCE EARLY
IN 2019
Source text for Eikon: urn:newsml:reuters.com:*:nGNE14XP8w
Further company coverage: PIX.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Pixium Vision SA
See all newsBrief: Pixium Vision SA Says Paris Commercial Court Postponed Decision On Takeover Offer Filed On Nov 20, 2023
Brief: Pixium Vision: opening of judicial liquidation proceedings has been postponed to later date
Brief: Pixium Vision Announces Decision About Adoption Of Sale Plan, Opening Of Judicial Liquidation Proceedings Planned For Jan 16, 2024
Brief: Pixium Vision SA Announces Conversion Of Safeguard Proceedings Into Receivership
Brief: Pixium Vision Announces Tender Process For Purpose Of Finding Buyers To Acquire Company's Business Will Be Published Tomorrow